Animation - Targeted Therapy in NSCLC
Slide Show - Targeted Therapy in NSCLC
1.
What is targeted therapy for lung cancer?
2.
What targeted therapies are used for people with the EGFR mutation?
3.
What targeted therapies are used for people with the ALK mutation?
4.
What targeted therapies are used for people with the ROS1 mutation?
5.
What is the importance of combination therapies for BRAF?
6.
What is the future of combination therapy for lung cancer?
7.
Can biomarker testing help identify clinical trial opportunities for me?
8.
How can communities of color increase their participation in clinical trials?
Expert Video - What is the importance of combination therapies for BRAF?
Dr. Robert Winn, an expert on cancer mutations, explains the importance of combination therapies for BRAF mutations in non-small-cell lung cancer. BRAF mutations are targeted with combination, or two-drug, therapy. He explains how using more than one drug can be more effective at treating non-small-cell lung cancer and how this approach applies to other mutations as well.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
Section: Targeted Therapy in NSCLC
Expert Videos
Animation - Targeted Therapy in NSCLC
Slide Show - Targeted Therapy in NSCLC
1.
What is targeted therapy for lung cancer?
2.
What targeted therapies are used for people with the EGFR mutation?
3.
What targeted therapies are used for people with the ALK mutation?
4.
What targeted therapies are used for people with the ROS1 mutation?
5.
What is the importance of combination therapies for BRAF?
6.
What is the future of combination therapy for lung cancer?
7.
Can biomarker testing help identify clinical trial opportunities for me?
8.
How can communities of color increase their participation in clinical trials?
